The Effect of Cold Storage Solutions on Ischemic Injury in Lung Transplantation
A Prospective, Controlled, Randomized Study on the Effect of Cold Storage Solutions on Complement Activation and Other Mediators of Ischemic Injury in Lung Transplantation
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The purpose of this study is to compare 2 different cold storage solutions, used to preserve donor lungs for lung transplantation, and their effect on cytokine activation related to ischemic reperfusion injury. Primary endpoint is 30 day survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2000
Longer than P75 for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2005
CompletedFirst Submitted
Initial submission to the registry
January 31, 2006
CompletedFirst Posted
Study publicly available on registry
February 1, 2006
CompletedSeptember 28, 2023
December 1, 2017
January 31, 2006
September 26, 2023
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Any patient undergoing a lung trasnplant at Johns Hopkins Hospital -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
John V. Conte, M.D.
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 31, 2006
First Posted
February 1, 2006
Study Start
December 1, 2000
Study Completion
September 1, 2005
Last Updated
September 28, 2023
Record last verified: 2017-12